In vitro antifungal activity of miltefosine and levamisole: their impact on ergosterol biosynthesis and cell permeability of dimorphic fungi - PubMed
In vitro antifungal activity of miltefosine and levamisole: their impact on ergosterol biosynthesis and cell permeability of dimorphic fungi
R S N Brilhante et al. J Appl Microbiol. 2015 Oct.
Abstract
Aims: This study aimed to evaluate the in vitro activity of miltefosine and levamisole against strains of Coccidioides posadasii in the filamentous phase and strains of Histoplasma capsulatum in filamentous and yeast phases.
Methods and results: Strains of C. posadasii in the filamentous phase (n = 22) and strains of H. capsulatum in filamentous (n = 40) and yeast phases (n = 13) were, respectively, submitted to broth macrodilution and broth microdilution methods, as described by the Clinical and Laboratory Standards Institute, to determine the minimum inhibitory concentration (MIC) and the minimum fungicidal concentration (MFC) of miltefosine and levamisole. The effect of the drugs on cell membrane permeability under osmotic stress conditions and total ergosterol production were also assessed, along with quantification of extravasated molecules. The results show the inhibitory effect of levamisole and miltefosine against C. posadasii and H. capsulatum and the effect of these drugs on ergosterol synthesis and the permeability of the plasma membrane using subinhibitory concentrations against strains subjected to osmotic stress. Levamisole was also able to cause the release of nucleic acids.
Conclusions: Miltefosine and levamisole are capable of inhibiting the in vitro growth of C. posadasii and H. capsulatum, probably by altering the permeability of the cellular membrane.
Significance and impact of the study: This work presents alternatives for the treatment of histoplasmosis and coccidioidomycosis, raising the possibility of the use of miltefosine and levamisole as adjuvants in antifungal therapy, providing perspectives for the design of in vivo studies.
Keywords: Coccidioides posadasii; Histoplasma capsulatum; antifungal activity; inhibitory effect; levamisole; miltefosine.
© 2015 The Society for Applied Microbiology.
Similar articles
-
Brilhante RS, de Lima RA, Caetano EP, Leite JJ, Castelo-Branco Dde S, Ribeiro JF, Bandeira Tde J, Cordeiro Rde A, Monteiro AJ, Sidrim JJ, Rocha MF. Brilhante RS, et al. Antimicrob Agents Chemother. 2013 May;57(5):2167-70. doi: 10.1128/AAC.02457-12. Epub 2013 Mar 4. Antimicrob Agents Chemother. 2013. PMID: 23459491 Free PMC article.
-
Brilhante RS, Caetano EP, Sidrim JJ, Cordeiro RA, Camargo ZP, Fechine MA, Lima RA, Castelo Branco DS, Marques FJ, Mesquita JR, Lima DT, Monteiro AJ, Rocha MF. Brilhante RS, et al. Mycoses. 2013 May;56(3):397-401. doi: 10.1111/myc.12025. Epub 2012 Dec 4. Mycoses. 2013. PMID: 23205615
-
Brilhante RS, Malaquias AD, Caetano EP, Castelo-Branco Dde S, Lima RA, Marques FJ, Silva NF, Alencar LP, Monteiro AJ, Camargo ZP, Bandeira Tde J, Rodrigues AM, Cordeiro Rde A, Moreira JL, Sidrim JJ, Rocha MF. Brilhante RS, et al. Med Mycol. 2014 Apr;52(3):320-5. doi: 10.1093/mmy/myt027. Epub 2014 Mar 23. Med Mycol. 2014. PMID: 24662247
-
Taborda CP, Buccheri R, Benard G, Duarte-Neto AN, Nosanchuk JD, Travassos LR. Taborda CP, et al. Curr Top Med Chem. 2018;18(15):1333-1348. doi: 10.2174/1568026618666181002112231. Curr Top Med Chem. 2018. PMID: 30277157 Review.
Cited by
-
Morphological and metabolic changes in an aged strain of Agaricus bisporus As2796.
Shu L, Zeng Z, Dai J, Cheng Y, Lu Y, Chen M, Zeng H. Shu L, et al. Appl Microbiol Biotechnol. 2021 Oct;105(20):7997-8007. doi: 10.1007/s00253-021-11526-1. Epub 2021 Oct 1. Appl Microbiol Biotechnol. 2021. PMID: 34596723
-
Dos Santos GMP, Borba-Santos LP, Vila T, Ferreira Gremião ID, Pereira SA, De Souza W, Rozental S. Dos Santos GMP, et al. Pathogens. 2022 Feb 3;11(2):206. doi: 10.3390/pathogens11020206. Pathogens. 2022. PMID: 35215149 Free PMC article.
-
Miltefosine: A Repurposing Drug against Mucorales Pathogens.
Xisto MIDDS, Rollin-Pinheiro R, Rochetti VP, Castro-Almeida Y, Borba-Santos LP, Santos-Freitas GMPD, Cypriano J, Abreu FÁ, Rozental S, Barreto-Bergter E. Xisto MIDDS, et al. J Fungi (Basel). 2023 Dec 4;9(12):1166. doi: 10.3390/jof9121166. J Fungi (Basel). 2023. PMID: 38132767 Free PMC article.
-
Loreto ES, Tondolo JSM, Oliveira DC, Santurio JM, Alves SH. Loreto ES, et al. Antimicrob Agents Chemother. 2018 Feb 23;62(3):e01678-17. doi: 10.1128/AAC.01678-17. Print 2018 Mar. Antimicrob Agents Chemother. 2018. PMID: 29311087 Free PMC article.
-
Rollin-Pinheiro R, Almeida YC, Rochetti VP, Xisto MIDDS, Borba-Santos LP, Rozental S, Barreto-Bergter E. Rollin-Pinheiro R, et al. Front Cell Infect Microbiol. 2021 Jul 23;11:698662. doi: 10.3389/fcimb.2021.698662. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34368017 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials